spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cannabidiol 

 HSMN NewsFeed - 27 Jan 2022
SciSparc Presents New Leadership Lineup
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2020
Jay Pharma to File IND Applications to FDA for a clinical study of proprietary formulations in Radiodermatitis and a combination Therapy in Glioblastoma
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Feb 2020
Sara Dakar to Join Jay Pharma as Vice President, Product Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jul 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Sep 2018
Epilepsy Foundation Statement on DEA's Scheduling of Epidiolex(R)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jun 2018
Intec Pharma Appoints William Bradley Hayes to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 27 Jun 2018
Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 May 2018
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
Devices Drug Delivery Licensing
 HSMN NewsFeed - 2 Apr 2018
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Dec 2017
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex(R) (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Dec 2017
FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2017
Intec Pharma Names Walt Linscott as Chief Administrative Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 27 Jul 2017
Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 May 2017
Intec Pharma Announces CEO Change
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Apr 2017
Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jun 2016
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex(R) (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2016
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Nov 2015
Insys Therapeutics Announces Senior Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2015
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 May 2015
GW Pharmaceuticals Initiates Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2015
GW Pharmaceuticals Initiates First Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Jul 2014
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Apr 2014
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2014
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jul 2013
GW Pharmaceuticals plc Announces Sativex(R) Launch in Italy
Biopharmaceuticals Neurology Product Launch
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.